Kobzeva N.D., Martynov A.I., Terentiev V.P., Batyushin M.M.
Peculiarities of chronic kidney disease progression in the long-term period in multifocal atherosclerosis patients
|
№6 / 2022
|
Sycheva A.S., Malyavina M.A., Tebueva L.V., Grigorievsky E.D., Kebina A.L., Vertkin A.L., Solodov A.A., Semenyakin I.V., Levchenko O.V., Yanushevich O.O.
Peculiarities of COVID-19 coronavirus infection course in patients with comorbid pathology
|
№6 / 2022
|
Borisov A.Yu., Chepurnaya O.P., Kichigin V.A., Karushkin A.A., Basyrova L.R., Kochemirova T.N.
Causes and outcomes of severe acute kidney injury in the Chuvash Republic in 2018–2019
|
№2 (приложение) / 2022
|
Larina V.N., Lunev V.I., Larin V.G., Golovko M.G., Sidorova V.P.
Prognostication of the clinical course of heart failure in elderly patients having chronic kidney disease
|
№9 / 2021
|
Milovanova L.Yu., Taranova M.V., Milovanova S.Yu., Kozlov V.V., Beketov V.D., Volkov A.V., Pasechnik A.I., Moiseev S.V.
Cardiac and vessels remodeling as a result of FGF-23/Klotho factors imbalance in chronic kidney disease patients
|
№6 / 2021
|
Kolomyitseva M.N., Gasanov M.Z., Batyushin M.M.
Contribution of systemic inflammation to the development of vascular remodeling in patients with chronic kidney disease and sarcopenia
|
№5 / 2021
|
Poteshkina N.G., Krylova N.S., Mikheeva L.V., Khadzegova A.B.
Anticoagulant therapy in case of atrial fibrillation for patients with chronic kidney disease
|
№3 / 2020
|
Murkamilov I.T., Aitbaev K.A., Fomin V.V., Murkamilova Zh.A., Rayimzhanov Z.R., Redjapova N.A., Yusupov F.A.
Braking progression of nephro- and cerebrovascular complications during atrial fibrillation: opportunities of rivaroxaban
|
№1 / 2020
|
Bobkova I.N., Gussaova S.S., Stavrovskaya E.V.
Kidney damage in case of obesity: variants of clinical course, mechanisms of development
|
№6 / 2019
|
Bakulin I.G., Abatsieva M. P., Skalinskaya M.I., Zhuravleva M.S.
Clinical and medico-social significance of NAFLD through the prism of comorbidity
|
№6 / 2019
|
Mazurov V.I., Petrova M.S., Gaydukova I.Z., Inamova O.V., Fonturenko A.Yu., Gaydukova E.K., Shapovalov A.A., Nagirnyak I.M.
Features of gouty arthritis according to the St. Petersburg City register of gout (2016–2018 years)
|
№6 / 2019
|
Murkamilov I.T., Aitbaev K.A., Fomin V.V., Murkamilova Zh.A.
Cystatin C as a marker of chronic kidney desease
|
№4 / 2019
|